Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
Rafael Naime Ruggiero, Matheus Teixeira Rossignoli, Jana Batista De Ross, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders
Rafael Naime Ruggiero, Matheus Teixeira Rossignoli, Danilo Benette Marques, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 59
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
Tibor Štark, Jana Kučerová, Fabio Arturo Iannotti, et al.
Neuropharmacology (2018) Vol. 146, pp. 212-221
Closed Access | Times Cited: 76
Multifunctional TRPV1 Ion Channels in Physiology and Pathology with Focus on the Brain, Vasculature, and Some Visceral Systems
Maksim V. Storozhuk, Olesia F. Moroz, Alexander V. Zholos
BioMed Research International (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 74
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30
Understanding translational research in schizophrenia: A novel insight into animal models
Jonaid Ahmad Malik, Zahid Yaseen, Thotapalli Lahari, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 4, pp. 3767-3785
Open Access | Times Cited: 20
TRPV1 Channels in the Central Nervous System as Drug Targets
Loris A. Chahl
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 756-756
Open Access | Times Cited: 6
Ketamine’s dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant
Eli Lavender, Mika Hirasawa-Fujita, Edward F. Domino
Behavioural Brain Research (2020) Vol. 390, pp. 112631-112631
Closed Access | Times Cited: 44
Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats
Ewa Kozela, Martyna Krawczyk, Tomasz Kos, et al.
Molecular Neurobiology (2019) Vol. 57, Iss. 3, pp. 1733-1747
Closed Access | Times Cited: 36
Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats
Rafał Kossakowski, Eberhard Schlicker, Marek Toczek, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 35
Cannabidiol and Neurodevelopmental Disorders in Children
Keith Cheung, Murray D. Mitchell, Helen Heussler
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 29
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology
Martina Di Bartolomeo, Tibor Štark, Serena Di Martino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3907-3907
Open Access | Times Cited: 12
Endogenous antagonists of N‐methyl‐d‐aspartate receptor in schizophrenia
Pascal Jorratt, Cyril Höschl, Saak V. Ovsepian
Alzheimer s & Dementia (2020) Vol. 17, Iss. 5, pp. 888-905
Closed Access | Times Cited: 21
Involvement of the TRPV1 receptor and the endocannabinoid system in schizophrenia
Junjie Huang, Huan Huang, Moyin Liu, et al.
Brain Research Bulletin (2024) Vol. 215, pp. 111007-111007
Open Access | Times Cited: 2
A large-scale optogenetic neurophysiology platform for improving accessibility in NHP behavioral experiments
Devon J. Griggs, Julien Bloch, Noah Stanis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
Valéria de Almeida, Raquel Levin, Fernanda Fiel Peres, et al.
Neuropharmacology (2019) Vol. 155, pp. 44-53
Closed Access | Times Cited: 20
Long-term potentiation prevents ketamine-induced aberrant neurophysiological dynamics in the hippocampus-prefrontal cortex pathway in vivo
Cleiton Lopes‐Aguiar, Rafael Naime Ruggiero, Matheus Teixeira Rossignoli, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Cannabis Use and Mental Illness: Understanding Circuit Dysfunction Through Preclinical Models
Bryan W. Jenkins, Jibran Y. Khokhar
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 17
Input Convergence, Synaptic Plasticity and Functional Coupling Across Hippocampal-Prefrontal-Thalamic Circuits
Lézio Soares Bueno-Júnior, João Pereira Leite
Frontiers in Neural Circuits (2018) Vol. 12
Open Access | Times Cited: 20
The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment
Allan Radaic, Daniel Martins‐de‐Souza
Nanomedicine Nanotechnology Biology and Medicine (2020) Vol. 28, pp. 102222-102222
Closed Access | Times Cited: 16
Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases
Martin Helcman, Karel Šmejkal
Phytochemistry Reviews (2021) Vol. 21, Iss. 2, pp. 429-470
Closed Access | Times Cited: 14
[Ursolic acid improved demyelination and interstitial fluid drainage disorders in schizophrenia mice].
Ren Long, Xin Mao, Tianzi Gao, et al.
PubMed (2024) Vol. 56, Iss. 3, pp. 487-494
Closed Access | Times Cited: 1
Optimized large-scale optogenetic interface for non-human primates
Devon J. Griggs, Karam Khateeb, S. Philips, et al.
(2019), pp. 3-3
Closed Access | Times Cited: 13
Red-hot chili receptors: A systematic review of TRPV1 antagonism in animal models of psychiatric disorders and addiction
Andrea Escelsior, Bruno Sterlini, Martino Belvederi Murri, et al.
Behavioural Brain Research (2020) Vol. 393, pp. 112734-112734
Open Access | Times Cited: 12
Effects of the cannabinoid receptor 1 positive allosteric modulator GAT211 and acute MK-801 on visual attention and impulsivity in rats assessed using the five-choice serial reaction time task
Timothy J. Onofrychuk, Shuang Cai, Dan L. McElroy, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 109, pp. 110235-110235
Closed Access | Times Cited: 10
Treatments for Social Interaction Impairment in Animal Models of Schizophrenia: A Critical Review and Meta-analysis
Reut Hazani, Michal Lavidor, Aron Weller
Schizophrenia Bulletin (2022) Vol. 48, Iss. 6, pp. 1179-1193
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top